Copyright © Inderes 2011 - present. All rights reserved.

Attana

0.01 SEK

+28.57 %

Less than 1K followers

ATANA

Nordic SME

Biotechnology & Pharmaceuticals

Health Care

+28.57 %
+28.57 %
0.00 %
-10.00 %
-64.00 %
+80.00 %
-92.45 %
-98.84 %
-94.15 %

Attana conducts research and development of pharmaceuticals. The company specializes in biological interaction characterization, which is used for analysis in the development of new drugs. The company's patented solutions are used in the study of binding properties and macrostructures in cells, proteins, viruses and bacteria. Operations are primarily in the Nordic region and Europe. The company was founded in 2002 and is headquartered in Stockholm.

Read more
Market cap
23.23M SEK
Turnover
521.14K SEK
Revenue
4.1M
EBIT %
-244.15 %
P/E
-
Dividend yield-%
-
Revenue and EBIT-%

Revenue M

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
27/2
2026

Annual report '25

ShowingAll content types

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Forum discussions
Attanalle 5 v pituinen sopimus USA:han, sopimuksella on positiivinen vaikutus kassavirtaan sopimuskauden aikana. Alkuvuodesta tuli uutinen yhteistyö- ja tutkimussopimuksesta Yhdysvaltalaisen yliopistosairaalan kanssa. Pienempiä uutisia on tullut myös uusista julkaistuista tutkimuksista...
4/25/2022, 1:58 PM
by Mikael Kahn
4
Cut your losses quickly is a pretty good saying for companies like these.
12/9/2023, 12:32 PM
by Warren Noutopöytätarjoilu
1
A share issue is incoming. I’m wondering if I should finally realize these -95% losses or continue to fund this sinking ship. Is anyone else still on board?
12/8/2023, 12:14 PM
by III21
1
News Powered by Cision Attana plans to move production of consumables to AroCell Attana can today announce that the company has begun a discussion about moving production of
5/5/2022, 4:47 PM
by PP2020
1
This multibagger seems to have multibagged in the other direction, meaning only 1/20th of the value is left.
12/9/2023, 11:10 AM
by Tunturisusi
0
Got a small pile souring at the bottom of my portfolio and I’m not really that excited to participate in the offering. I have to admit I haven’t followed the company’s activities at all lately.
12/9/2023, 8:13 AM
by ghoul
0
Börskollen Kvartalsrapport för perioden 1 januari - 31 mars 2022 i Attana AB Pressmeddelande i aktien Attana. Kvartalsrapport för perioden 1 januari - 31 mars 2022 i Attana AB. Financial overview (not audited by the company’s auditor): Net sales SEK 3.1 (1.1) million Other operating...
5/6/2022, 6:11 AM
by Tume
0
Read more on our forum
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.